Early research (Phase 1)Study completedNCT05518201
What this trial is testing
Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old
Who this might be right for
Penile CancerAnal CancerPIN-1+6 more
Shanghai Bovax Biotechnology Co., Ltd. 90